These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 18633185)

  • 21. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
    Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
    Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure.
    Feng W; Li W; Liu W; Wang F; Li Y; Yan W
    Exp Mol Pathol; 2009 Dec; 87(3):212-8. PubMed ID: 19527710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term administration of nifedipine attenuates cardiac remodeling and diastolic heart failure in hypertensive rats.
    Yamada T; Nagata K; Cheng XW; Obata K; Saka M; Miyachi M; Naruse K; Nishizawa T; Noda A; Izawa H; Kuzuya M; Okumura K; Murohara T; Yokota M
    Eur J Pharmacol; 2009 Aug; 615(1-3):163-70. PubMed ID: 19501083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac remodeling and failure From molecules to man (Part II).
    Fedak PW; Verma S; Weisel RD; Li RK
    Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.
    Matsusaka H; Ide T; Matsushima S; Ikeuchi M; Kubota T; Sunagawa K; Kinugawa S; Tsutsui H
    Hypertension; 2006 Apr; 47(4):711-7. PubMed ID: 16505197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
    Szalay G; Sauter M; Haberland M; Zuegel U; Steinmeyer A; Kandolf R; Klingel K
    Circ Res; 2009 Apr; 104(7):851-9. PubMed ID: 19246678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
    Jayasankar V; Woo YJ; Bish LT; Pirolli TJ; Berry MF; Burdick J; Bhalla RC; Sharma RV; Gardner TJ; Sweeney HL
    Circulation; 2004 Sep; 110(11 Suppl 1):II180-6. PubMed ID: 15364860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular matrix remodeling in hypertensive heart disease.
    Shirwany A; Weber KT
    J Am Coll Cardiol; 2006 Jul; 48(1):97-8. PubMed ID: 16814654
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload.
    Janicki JS; Brower GL; Gardner JD; Forman MF; Stewart JA; Murray DB; Chancey AL
    Cardiovasc Res; 2006 Feb; 69(3):657-65. PubMed ID: 16376324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.
    Odashima M; Usui S; Takagi H; Hong C; Liu J; Yokota M; Sadoshima J
    Circ Res; 2007 May; 100(9):1344-52. PubMed ID: 17395874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
    Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
    Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy.
    Tozzi R; Palladini G; Fallarini S; Nano R; Gatti C; Presotto C; Schiavone A; Micheletti R; Ferrari P; Fogari R; Perlini S
    Am J Hypertens; 2007 Jun; 20(6):663-9. PubMed ID: 17531925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
    Ikonomidis JS; Gibson WC; Butler JE; McClister DM; Sweterlitsch SE; Thompson RP; Mukherjee R; Spinale FG
    Circulation; 2004 Sep; 110(11 Suppl 1):II268-73. PubMed ID: 15364874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of signaling molecules and matrix metalloproteinases in right ventricular myocardium of rats with pulmonary hypertension.
    Umar S; Hessel M; Steendijk P; Bax W; Schutte C; Schalij M; van der Wall E; Atsma D; van der Laarse A
    Pathol Res Pract; 2007; 203(12):863-72. PubMed ID: 17913382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway.
    Xiao H; Ma X; Feng W; Fu Y; Lu Z; Xu M; Shen Q; Zhu Y; Zhang Y
    Cardiovasc Res; 2010 Aug; 87(3):504-13. PubMed ID: 20200042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.
    Heymans S; Pauschinger M; De Palma A; Kallwellis-Opara A; Rutschow S; Swinnen M; Vanhoutte D; Gao F; Torpai R; Baker AH; Padalko E; Neyts J; Schultheiss HP; Van de Werf F; Carmeliet P; Pinto YM
    Circulation; 2006 Aug; 114(6):565-73. PubMed ID: 16880329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
    Weeks KL; Gao X; Du XJ; Boey EJ; Matsumoto A; Bernardo BC; Kiriazis H; Cemerlang N; Tan JW; Tham YK; Franke TF; Qian H; Bogoyevitch MA; Woodcock EA; Febbraio MA; Gregorevic P; McMullen JR
    Circ Heart Fail; 2012 Jul; 5(4):523-34. PubMed ID: 22705768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.
    Van Linthout S; Seeland U; Riad A; Eckhardt O; Hohl M; Dhayat N; Richter U; Fischer JW; Böhm M; Pauschinger M; Schultheiss HP; Tschöpe C
    Basic Res Cardiol; 2008 Jul; 103(4):319-27. PubMed ID: 18347835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.